Functional Interactions Between Peripheral P2X3 and TRP Channels

外设 P2X3 和 TRP 通道之间的功能交互

基本信息

  • 批准号:
    8261843
  • 负责人:
  • 金额:
    $ 1.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-03-01 至 2012-10-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Myofascial pain conditions, including those associated with temporomandibular joint and muscle disorder (TMD) affect millions of people. These conditions are extremely difficult to treat, often leaving patients with a poor quality of life. The long-term objective of this application is two-fold: 1) to elucidate novel cellular signaling mechanisms underlying the development of mechanical hyperalgesia, a major symptom associated with myofascial pain conditions such as TMD and 2) to use this scientific endeavor as a training vehicle for acquiring the knowledge and skills needed to become a successful independent pain scientist. P2X3 receptors are nonselective cation channels that have been implicated in nociceptive processing, including the mediation of mechanical hyperalgesia. TRPV1 and TRPA1 (TRPV1/A1) channels have also previously been implicated in the development of mechanical hyperalgesia in muscle. They are suggested to be inflammatory signal integrators following the activation of pro-inflammatory receptors. Preliminary data suggests direct activation of P2X3 induces mechanical hyperalgesia and pretreatment of the same muscle with TRPV1/A1 antagonists inhibits this hyperalgesia. Calcium permeable P2X3 channel activation could lead to the initiation of signaling cascades which results in the activation of kinases such as CaMKII and PKC, which are known to sensitize TRP channels. This study proposes to use behavioral assays, calcium imaging, and biochemical means to characterize the functional interactions between P2X3 and TRPV1/A1. These same techniques will also be used to elucidate the signaling pathways mediating these interactions. The identification of new mechanisms underlying mechanical hyperalgesia during myositis conditions could contribute to alternative treatment strategies for the management of TMD and other muscle pain conditions. PUBLIC HEALTH RELEVANCE: Orofacial muscle pain particularly that associated with temporomandibular joint and muscle disorder affects approximately 12% of the population. The currently available treatments are inadequate because of the ambiguity surrounding the underlying pathology of the condition. In accordance with the missions of the NIDCR and the FOA: PA-10-108 this study proposes to 1) determine novel cellular mechanisms linking purinergic and TRP channels which could serve as future therapeutic targets and 2) provide a vehicle for the development and training of a rising pain scientist.
描述(由申请人提供):肌筋膜疼痛状况,包括与颞下颌关节和肌肉疾病(TMD)相关的疼痛,影响了数百万人。这些情况极难治疗,往往使患者的生活质量很差。这项应用的长期目标有两个方面:1)阐明机械性痛觉过敏(与肌筋膜疼痛状况(如TMD)相关的主要症状)发展的新细胞信号机制;2)利用这一科学努力作为获得知识和技能的培训工具,成为一名成功的独立疼痛科学家。P2X3受体是一种非选择性阳离子通道,与伤害性加工有关,包括介导机械性痛觉过敏。TRPV1和TRPA1 (TRPV1/A1)通道先前也与肌肉中机械性痛觉过敏的发生有关。它们被认为是促炎受体激活后的炎症信号整合者。初步数据表明,直接激活P2X3可诱导机械性痛觉过敏,而用TRPV1/A1拮抗剂预处理同一块肌肉可抑制这种痛觉过敏。钙渗透性P2X3通道激活可能导致信号级联反应的启动,从而导致CaMKII和PKC等激酶的激活,这些激酶已知对TRP通道敏感。本研究建议使用行为分析、钙成像和生化手段来表征P2X3和TRPV1/A1之间的功能相互作用。这些相同的技术也将用于阐明介导这些相互作用的信号通路。在肌炎条件下机械性痛觉过敏的新机制的确定可能有助于TMD和其他肌肉疼痛条件管理的替代治疗策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jami Lynn Saloman其他文献

Jami Lynn Saloman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jami Lynn Saloman', 18)}}的其他基金

Biomarkers to stratify pain severity and type in pancreatic disease
用于对胰腺疾病疼痛严重程度和类型进行分层的生物标志物
  • 批准号:
    10707763
  • 财政年份:
    2023
  • 资助金额:
    $ 1.93万
  • 项目类别:
Mechanism-based Approach to Pain in Chronic Pancreatitis (MAP-CP Study)
基于机制的慢性胰腺炎疼痛治疗方法(MAP-CP 研究)
  • 批准号:
    10263243
  • 财政年份:
    2020
  • 资助金额:
    $ 1.93万
  • 项目类别:
Mechanism-based Approach to Pain in Chronic Pancreatitis (MAP-CP Study)
基于机制的慢性胰腺炎疼痛治疗方法(MAP-CP 研究)
  • 批准号:
    9976126
  • 财政年份:
    2020
  • 资助金额:
    $ 1.93万
  • 项目类别:
Neuropathic vs. inflammatory pain in chronic pancreatitis: can unique biomarkers be identified to guide mechanistic approaches to pain treatment?
慢性胰腺炎的神经性疼痛与炎性疼痛:是否可以确定独特的生物标志物来指导疼痛治疗的机制方法?
  • 批准号:
    10335169
  • 财政年份:
    2019
  • 资助金额:
    $ 1.93万
  • 项目类别:
Neuropathic vs. inflammatory pain in chronic pancreatitis: can unique biomarkers be identified to guide mechanistic approaches to pain treatment?
慢性胰腺炎的神经性疼痛与炎性疼痛:是否可以确定独特的生物标志物来指导疼痛治疗的机制方法?
  • 批准号:
    9902440
  • 财政年份:
    2019
  • 资助金额:
    $ 1.93万
  • 项目类别:
Neuropathic vs. inflammatory pain in chronic pancreatitis: can unique biomarkers be identified to guide mechanistic approaches to pain treatment?
慢性胰腺炎的神经性疼痛与炎性疼痛:是否可以确定独特的生物标志物来指导疼痛治疗的机制方法?
  • 批准号:
    10555264
  • 财政年份:
    2019
  • 资助金额:
    $ 1.93万
  • 项目类别:
Neuropathic vs. inflammatory pain in chronic pancreatitis: can unique biomarkers be identified to guide mechanistic approaches to pain treatment?
慢性胰腺炎的神经性疼痛与炎性疼痛:是否可以确定独特的生物标志物来指导疼痛治疗的机制方法?
  • 批准号:
    10083736
  • 财政年份:
    2019
  • 资助金额:
    $ 1.93万
  • 项目类别:
Functional Interactions Between Peripheral P2X3 and TRP Channels
外设 P2X3 和 TRP 通道之间的功能交互
  • 批准号:
    8060323
  • 财政年份:
    2011
  • 资助金额:
    $ 1.93万
  • 项目类别:

相似海外基金

Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial
基于网络的疼痛应对技能培训,以改善乳腺癌幸存者芳香酶抑制剂相关关节痛引起的疼痛和依从性差(SKIP-关节痛):一项随机对照试验
  • 批准号:
    10439192
  • 财政年份:
    2022
  • 资助金额:
    $ 1.93万
  • 项目类别:
Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial
基于网络的疼痛应对技能培训,以改善乳腺癌幸存者芳香酶抑制剂相关关节痛引起的疼痛和依从性差(SKIP-关节痛):一项随机对照试验
  • 批准号:
    10630101
  • 财政年份:
    2022
  • 资助金额:
    $ 1.93万
  • 项目类别:
Clarification of the mechanism for arthralgia, one of the premenstrual syndrome symptoms, focusing on the extracellular matrix
阐明经前综合症症状之一的关节痛的机制,重点关注细胞外基质
  • 批准号:
    17K11262
  • 财政年份:
    2017
  • 资助金额:
    $ 1.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Estrogen Deprivation and Aromatase Inhibitor associated Arthralgia
雌激素剥夺和芳香酶抑制剂相关的关节痛
  • 批准号:
    8086843
  • 财政年份:
    2011
  • 资助金额:
    $ 1.93万
  • 项目类别:
Estrogen Deprivation and Aromatase Inhibitor associated Arthralgia
雌激素剥夺和芳香酶抑制剂相关的关节痛
  • 批准号:
    8291088
  • 财政年份:
    2011
  • 资助金额:
    $ 1.93万
  • 项目类别:
Estrogen Deprivation and Aromatase Inhibitor associated Arthralgia
雌激素剥夺和芳香酶抑制剂相关的关节痛
  • 批准号:
    8660047
  • 财政年份:
    2011
  • 资助金额:
    $ 1.93万
  • 项目类别:
Estrogen Deprivation and Aromatase Inhibitor associated Arthralgia
雌激素剥夺和芳香酶抑制剂相关的关节痛
  • 批准号:
    8847227
  • 财政年份:
    2011
  • 资助金额:
    $ 1.93万
  • 项目类别:
Development of the way of Nordic Walking for elderly people with arthralgia and verification of its intervention effect.
老年人关节痛北欧式健走方式的开发及干预效果验证
  • 批准号:
    23700636
  • 财政年份:
    2011
  • 资助金额:
    $ 1.93万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Estrogen Deprivation and Aromatase Inhibitor associated Arthralgia
雌激素剥夺和芳香酶抑制剂相关的关节痛
  • 批准号:
    8461818
  • 财政年份:
    2011
  • 资助金额:
    $ 1.93万
  • 项目类别:
Estrogen Deprivation and Aromatase Inhibitor associated Arthralgia
雌激素剥夺和芳香酶抑制剂相关的关节痛
  • 批准号:
    9276333
  • 财政年份:
    2011
  • 资助金额:
    $ 1.93万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了